- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
FDA clears software, MRI coil, and scanner
Several products have gained clearance for marketing in the U.S. Passing FDA muster were Vital Images' Vscore, a cardiac CT option featuring AutoGate for use on the company's Vitrea 2 workstation; Surgi-Vision's intravascular MRI coil; and Marconi's
Several products have gained clearance for marketing in the U.S. Passing FDA muster were Vital Images' Vscore, a cardiac CT option featuring AutoGate for use on the company's Vitrea 2 workstation; Surgi-Vision's intravascular MRI coil; and Marconi's Infinion 1.5T MRI scanner. Vital Images' VScore with AutoGate determines the phase of the cardiac cycle at which each CT slice was recorded, automatically selecting the images of the heart least affected by cardiac motion without an ECG signal. Called Intercept, the disposable coil from Surgi-Vision is designed to be threaded into arteries or veins to detect early signs of blood vessel disease in conjunction with standard MRI scanners. Infinion 1.5T is a short-bore whole-body MRI system.
2/28/01, Issue # 1504, page 6.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
